ArticleClinical rheumatology2025
The association between serum 25-hydroxyvitamin D levels and clinical outcomes in Chinese adult inpatients: a retrospective cohort study.
Article in Clinical rheumatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesPrevious studies reported the controvertible association between serum 25-hydroxyvitamin D [25(OH)D] level and clinical outcomes, however, whether serum 25(OH)D level were associated with length of hospital stay (LOS) and mortality remained uncertain.
methodsParticipants were recruited from three teaching hospitals between January 1, 2018 and October 31, 2022 in Shanghai and Beijing, China. Serum concentration of 25(OH)D and other clinical information was collected from medical records. All participants were classified as following: deficient (< 12 ng/ml), insufficient (12-20 ng/ml), and sufficient (≥ 20 ng/ml) based on serum 25(OH)D levels.
resultsA total number of 17,404 inpatients [10,050 men and 7529 women, aged 63.0 (50.0, 71.0) years] were included in the analysis. Generalized linear model analysis demonstrated that 25(OH)D deficient group had an increase of 1.34 days in LOS compared to the sufficient group (β = 1.34; 95% CI 1.06 ~ 1.62; p < 0.001) after adjusting for potential covariates. For a per standard deviation (SD) increase in 25(OH)D level (≈7.86 ng/ml), LOS decreased by 0.50 days (β = - 0.50; 95% CI - 0.61 ~ - 0.39; p trend < 0.001). The results of the subgroup analysis were consistent with the main results. Multiple logistic regression demonstrated that the risk of mortality in 25(OH)D deficient group was 2.63 times higher than that in the sufficient group (OR = 2.63; 95% CI 1.35 ~ 5.13; p = 0.001) in the fully adjusted model. For a per SD increase in 25(OH)D level, the risk of mortality decreased by 35% (OR = 0.65; 95% CI 0.50 ~ 0.86; p trend < 0.001).
conclusionVitamin D deficiency is associated with both longer LOS and increased risk of mortality in hospitalized patients. Keypoints • Among hospitalized adult patients who had their vitamin D levels routinely tested (indicating potential risk factors), a high prevalence (approximately 70%) of vitamin D deficiency or insufficiency was observed. • The increase in serum level of vitamin D was associated with both shorter length of hospital stays and lower risk of mortality.
Indexed as
Identifiers
40781170What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.